Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IPSEF

Recent news which mentions IPSEF

FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo
Tickers GNFT IPSEF IPSEY NEWS
Tags Benzinga IPSEF Media
From Benzinga
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
Tickers EXEL IPSEF IPSEY RHHBF
Tags Market News Benzinga Trading Ideas
From Benzinga
What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
Tickers CBAY DRRX GNFT ICPT
Tags General Movers News
From Benzinga
France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline
Tickers ALBO IPSEF IPSEY
Tags Benzinga IPSEF Trading Ideas
From Benzinga
Why Merrimack Shares Are Surging Over 200% Today?
Tickers IPSEF IPSEY MACK
Tags why it's moving News Briefs
From Benzinga
Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure
Tickers IPSEF IPSEY MACK
Tags Health Care IPSEY Biotech
From Benzinga
Why Is Epizyme (EPZM) Stock Up 75% Today?
Tickers EPZM IPSEF
Tags Market News Today's Market NASDAQ:EPZM,OTCMKTS:IPSEF
From InvestorPlace
Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why
Tickers EPZM IPSEF IPSEY
Tags M&A General Movers
From Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags EXEL Market News Benzinga
From Benzinga
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags EXEL Briefs News
From Benzinga
Ipsen's Sohonos Scores Canadian Approval For Rare Connective Tissue Disease
Tickers IPSEF IPSEY
Tags Biotech Briefs News
From Benzinga
Genfit Shares Rally After Ipsen Buys Rights To Its Late-Stage Kidney Disease Treatment Hopeful
Tickers GNFT IPSEF IPSEY
Tags Market News Long Ideas Benzinga
From Benzinga
Ipsen Stock Declines After Pulling Rare Disease Application
Tickers IPSEF IPSEY
Tags Biotech Health Care IPSEY
From Benzinga
Exicure Stock Surges On Over $1B Option Licensing Pact With Ipsen For Rare Neurodegenerative Disorders
Tickers IPSEF IPSEY XCUR
Tags Movers News Briefs
From Benzinga
Ipsen Beefs Up Pre-Clinical Oncology Pipeline With Over $850M Deal With BAKX Therapeutics
Tickers IPSEF IPSEY
Tags Benzinga IPSEF Market News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.